A prospective, time-series design, multicenter study on the effect of telmisartan on intra-renal RAS in type 2 diabetes.

Trial Profile

A prospective, time-series design, multicenter study on the effect of telmisartan on intra-renal RAS in type 2 diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Diabetic nephropathies
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Nov 2016 Status changed from recruiting to completed.
    • 06 Apr 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 15 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top